Efficacy of Pegylated interferon α-2a and α-2b in patients with genotype 1 chronic hepatitis C: a meta-analysis.
about
Recent Advances in Antiviral Therapy for Chronic Hepatitis CHepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antiviralsTreatment outcome in chronic hepatitis C infection: a four years survey among Iranian patients.Hepatic flares in chronic hepatitis C: spontaneous exacerbation vs hepatotropic viruses superinfection.MK-5172 : a second-generation protease inhibitor for the treatment of hepatitis C virus infection.Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus.Peg-interferon plus ribavirin with or without boceprevir or telaprevir for HCV genotype 1: a meta-analysis on the role of response predictorsRole of genetic polymorphisms in hepatitis C virus chronic infection.Hepatocellular carcinoma in Asia: Prevention strategy and planning.Direct medical care costs associated with patients diagnosed with chronic HCV.Interferon-Related Depression: A Primer on Mechanisms, Treatment, and Prevention of a Common Clinical Problem.Alanine aminotransferase normalization at week 8 predicts viral response during hepatitis C treatment.Ledipasvir : a novel synthetic antiviral for the treatment of HCV infection.Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection.Ombitasvir: a potent pan-genotypic inhibitor of NS5A for the treatment of hepatitis C virus infection.Relative efficacy and safety of simeprevir and telaprevir in treatment-naïve hepatitis C-infected patients in a Japanese population: A Bayesian network meta-analysis.Treatment of chronic hepatitis C in patients with HIV/HCV coinfectionComparative efficacy and safety of daclatasvir/asunaprevir versus IFN-based regimens in genotype 1b hepatitis C virus infection.Discontinued drugs in 2012 - 2013: hepatitis C virus infection.Treatment rate and factors related to interferon-based treatment initiation for chronic hepatitis C in South Korea.Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection.
P2860
Q26750476-D8933F30-04A6-46F8-BF86-1EF345657C9AQ26782033-A6B7D049-CA66-4641-AA6F-F0F148E76CCCQ33422617-20B1533B-D90E-4E4B-AAFD-DE903B831E4CQ33735206-A3DF02A8-212A-4FEC-8063-18593684D0C7Q34411907-D9192BB0-59EF-491E-9BF3-34C86D6365F5Q34420891-5321A19B-316E-4340-AFFF-B9577CF75F66Q35146790-CE276498-E523-448F-A8D0-290B83DD80ACQ35779058-2FCF9B55-4E1E-4952-8A61-1F2C485FA61CQ35790424-04F3B2CF-E06A-4394-9D98-D562ADDADF67Q37078173-72BF3911-3D27-44DD-B610-D6D5FDD3E3C3Q37310556-8E6F0691-4E19-493B-B7B3-B817773302AFQ37408864-229E59B0-2AA2-4363-9F32-06F13BCD30DAQ38193198-CF1E83F8-F6F3-462C-9945-4372E264795DQ38233860-3543CB9B-381B-4151-88F2-7A841F809F9BQ38235178-C412C2E0-2534-4BD7-BF78-C51AD132B381Q38307721-A6B46C08-AF28-4995-B7C5-410AB67F0AF3Q38352572-E5C9FB69-8E4C-492F-AC51-117AEB4912C1Q38544516-107CD51E-2FC5-4529-87E5-1154933EDFC6Q39100351-76D056A2-3501-49BC-8EB0-C3CC6F51ECE8Q41089743-808BB2CC-0C50-471C-88F1-5CCAD536C722Q42245958-2173FC98-C2BE-4325-B753-BC44AC47AA81
P2860
Efficacy of Pegylated interferon α-2a and α-2b in patients with genotype 1 chronic hepatitis C: a meta-analysis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Efficacy of Pegylated interfer ...... hepatitis C: a meta-analysis.
@ast
Efficacy of Pegylated interfer ...... hepatitis C: a meta-analysis.
@en
Efficacy of Pegylated interfer ...... hepatitis C: a meta-analysis.
@nl
type
label
Efficacy of Pegylated interfer ...... hepatitis C: a meta-analysis.
@ast
Efficacy of Pegylated interfer ...... hepatitis C: a meta-analysis.
@en
Efficacy of Pegylated interfer ...... hepatitis C: a meta-analysis.
@nl
prefLabel
Efficacy of Pegylated interfer ...... hepatitis C: a meta-analysis.
@ast
Efficacy of Pegylated interfer ...... hepatitis C: a meta-analysis.
@en
Efficacy of Pegylated interfer ...... hepatitis C: a meta-analysis.
@nl
P2860
P50
P356
P1476
Efficacy of Pegylated interfer ...... hepatitis C: a meta-analysis.
@en
P2860
P2888
P356
10.1186/1471-2334-12-357
P50
P577
2012-12-18T00:00:00Z
P5875
P6179
1030213503